Biosciences Research & Commercialization Center of Western Michigan University Research Foundation
The Biosciences Research & Commercialization Center (BRCC) provides startup and gap funding to promising Michigan-based life sciences and medical device ventures entering the commercialization phase of development. Established in 2003 by the Michigan Legislature, the BRCC is located on Western Michigan University’s Parkview Campus, leveraging Kalamazoo’s rich heritage in scientific talent and pharmaceutical commercialization expertise. The center focuses on life sciences, aiming to foster economic development and return on investment through early development to commercialization phase support.
Biosciences Research & Commercialization Center of Western Michigan University Research Foundation
Portfolio
Secured additional funding for cavity identification and treatment. Recognized as a 2021 Best of Class Technology Award Winner. Won a competitive startup pitch event at the 2023 Yankee Dental Meeting.
#Life Sciences
Closed $46.9 million in Series B financing to advance ONL1204 into three retinal disease indications. Announced first patient dosed in Phase 2 clinical trial of first-in-class Fas-Inhibitor.
#Life Sciences
Announced close of $2.5 million round in Series A. Celebrated by NASDAQ.
#Medical Devices
Named to 'Top Ten Artificial Intelligence Solutions Provider'. Received ISO 13485:2016 and MDSAP certifications.
#Artificial Intelligence
Closed initial $3.3 million tranche of $9.8 million private placement. Lead product candidate included in consensus statement for pediatric acute kidney injury.
#Medical Devices
Closed Series C funding at $82M. Closed another $10M in Series C funding to fuel product development and market expansion.
#Biotechnology